Schedule I (Notes)

12 Months Ended

Dec. 31, 2017

Condensed Statement of Income Captions [Line Items]

Condensed Financial Information of Parent Company Only Disclosure [Text Block]

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Balance Sheets

(in millions, except per share data)	December 31, 2017			December 31, 2016
Assets
Current assets:
Cash and cash equivalents	$	359		$	180
Short-term notes receivable from subsidiaries	—			755
Other current assets	575			140
Total current assets	934			1,075
Equity in net assets of subsidiaries	76,231			60,593
Long-term notes receivable from subsidiaries	4,278			9,912
Other assets	839			248
Total assets	$	82,282		$	71,828
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$	502		$	452
Current portion of notes payable to subsidiaries	466			280
Commercial paper and current maturities of long-term debt	2,749			7,113
Total current liabilities	3,717			7,845
Long-term debt, less current maturities	28,318			25,657
Long-term notes payable to subsidiaries	1,518			—
Other liabilities	953			52
Total liabilities	34,506			33,554
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding	—			—
Common stock, $0.01 par value - 3,000 shares authorized; 969 and 952 issued and outstanding	10			10
Additional paid-in capital	1,703			—
Retained earnings	48,730			40,945
Accumulated other comprehensive loss	(2,667		)	(2,681		)
Total UnitedHealth Group shareholders’ equity	47,776			38,274
Total liabilities and shareholders’ equity	$	82,282		$	71,828

See Notes to the Condensed Financial Statements of Registrant

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Comprehensive Income

	For the Years Ended December 31,
(in millions)	2017			2016			2015
Revenues:
Investment and other income	$	527		$	522		$	396
Total revenues	527			522			396
Operating costs:
Operating costs	—			(22		)	(17		)
Interest expense	1,114			995			717
Total operating costs	1,114			973			700
Loss before income taxes	(587		)	(451		)	(304		)
Benefit for income taxes	214			165			111
Loss of parent company	(373		)	(286		)	(193		)
Equity in undistributed income of subsidiaries	10,931			7,303			6,006
Net earnings	10,558			7,017			5,813
Other comprehensive income (loss)	14			653			(1,942		)
Comprehensive income	$	10,572		$	7,670		$	3,871

See Notes to the Condensed Financial Statements of Registrant

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Cash Flows

	For the Years Ended December 31,
(in millions)	2017			2016			2015
Operating activities
Cash flows from operating activities	$	2,021		$	4,294		$	1,727
Investing activities
Repayments (issuances) of notes to subsidiaries	2,071			(824		)	(5,064		)
Cash paid for acquisitions	(2,313		)	(2,292		)	(12,270		)
Return of capital to parent company	3,375			2,143			4,375
Capital contributions to subsidiaries	(959		)	(765		)	(1,109		)
Other, net	—			168			140
Cash flows from (used for) investing activities	2,174			(1,570		)	(13,928		)
Financing activities
Common stock repurchases	(1,500		)	(1,280		)	(1,200		)
Proceeds from common stock issuances	688			429			402
Cash dividends paid	(2,773		)	(2,261		)	(1,786		)
(Repayments of) proceeds from commercial paper, net	(3,508		)	(382		)	3,666
Proceeds from issuance of long-term debt	5,291			3,968			11,982
Repayments of long-term debt	(3,472		)	(2,596		)	(1,041		)
Proceeds (repayments) of notes from subsidiary	1,704			(30		)	95
Other, net	(446		)	(421		)	(447		)
Cash flows (used for) from financing activities	(4,016		)	(2,573		)	11,671
Increase (decrease) in cash and cash equivalents	179			151			(530		)
Cash and cash equivalents, beginning of period	180			29			559
Cash and cash equivalents, end of period	$	359		$	180		$	29
Supplemental cash flow disclosures
Cash paid for interest	$	1,062		$	974		$	573
Cash paid for income taxes	3,455			4,557			4,294
Supplemental schedule of non-cash investing activities
Common stock issued for acquisitions	$	2,164		$	—		$	—
Conversion of note receivable from subsidiaries to equity	4,378			—			—

See Notes to the Condensed Financial Statements of Registrant

Schedule I

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Notes to Condensed Financial Statements

1.    Basis of Presentation

UnitedHealth Group’s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form 10-K. The accounting policies for the registrant are the same as those described in Note 2 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements.”

2.    Subsidiary Transactions

Investment in Subsidiaries. UnitedHealth Group’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.

Dividends and Capital Distributions. Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $3.4 billion, $3.7 billion and $4.8 billion in 2017, 2016 and 2015, respectively. Additionally, $3.4 billion, $2.1 billion and $4.4 billion in cash were received as a return of capital to the parent company during 2017, 2016 and 2015, respectively.

3.    Commercial Paper and Long-Term Debt

Discussion of commercial paper and long-term debt can be found in Note 8 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements.” Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries that totaled $625 million and $200 million at December 31, 2017 and 2016, respectively.

Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:

(in millions)
2018	$	2,750
2019	1,750
2020	3,150
2021	2,400
2022	3,015
Thereafter	18,352

4. Commitments and Contingencies

For a summary of commitments and contingencies, see Note 12 of Notes to the Consolidated Financial Statements included in Part II, Item 8, “Financial Statements.”